116.49 USD
↘ 0.15 (0.13%)PRE MARKET (AS OF 04:20 AM EDT)
Abbott Laboratories
ABTNYSE • USD
Market: OPEN
ABT is currently priced at $116.49. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. On valuation, ABT trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 24, 2026.
Open?$116.64
High?$116.70
Low?$116.32
Prev. Close?$116.64
Volume?219
Avg. Volume?10.5M
VWAP?$116.40
Rel. Volume?0.00x
Bid / Ask
Bid?$115.84 × 200
Ask?$116.67 × 100
Spread?$0.83
Midpoint?$116.26
Valuation & Ratios
Market Cap?201.9B
Shares Out?1.7B
Float?1.7B
Float %?99.6%
P/E Ratio?37.21
P/B Ratio?3.95
EPS?$3.14
Dividend?2.11%
Ex-Dividend?N/A
News
Profile
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Themes
Employees
115.0K
Market Cap
201.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1949-04-19
Address
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-3500
Phone: (224) 667-6100
ABBOTT PARK, IL 60064-3500
Phone: (224) 667-6100
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?83
Momentum?21
Short Sent.?69
Piotroski F-Score?3/9Weak
Altman Z-Score?3.47Safe
Confidence?65%Moderate
Short InterestLow
Short % of Float?1.31%Low
Short Interest?22.6M
Days to Cover?1.7
Free Float1.7B
Avg Daily Volume13.6M
Settlement Date2026-07-31
Financial Health
Current Ratio?1.38Adequate
Quick Ratio?0.97Weak
Cash Ratio?0.29Low
Debt/Equity?0.64Moderate
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score56/100
P/E?37.2PRICEY▾
Peers36
S&P19
P/B?3.95FAIR▾
Peers60
S&P45
P/S?4.33FAIR▾
Peers64
S&P35
P/FCF?25.8FAIR▾
Peers55
S&P37
EV/EBITDA?21.3HIGH▾
Peers45
S&P21
EV/Sales?4.92FAIR▾
Peers64
S&P37
Returns & Efficiency
ROE?10.6%FAIR▾
Peers40
S&P37
ROA?5.0%FAIR▾
Peers45
S&P45
Cash Flow & Enterprise
FCF?$7.8B
Enterprise Value?$229.4B
Fundamentals ratios updated end of day